by Ashley | Apr 21, 2020 | COVID-19, FDA Approved Clinical Trial, Personalized Stem Cells, Press Release, Stem Cell Therapy
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...
by Ashley | Nov 25, 2019 | Blog, FDA Approved Clinical Trial, Knee Osteoarthritis, Stem Cell Therapy
As you may know, Personalized Stem Cells (PSC) has begun providing autologous adipose-derived stem cell therapy services to a select few physicians in the United States for the treatment of osteoarthritis in the knee through a clinical trial. This initial clinical...